+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cold And Flu Supplements Market Size, Share & Trends Analysis Report By Product (Herbal Extracts, Natural Molecules), By Distribution Channel (Pharmacies & Drug Stores, Online), And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 95 Pages
  • August 2023
  • Region: Global
  • Grand View Research
  • ID: 5876201
The global cold and flu supplements market size is expected to reach USD 36.61 billion in 2030, growing at a CAGR of 11.5% from 2023 to 2030.The increasing awareness about health and well-being has encouraged consumers to take a proactive approach toward managing their health, including preventing and treating cold and flu symptoms. People are no longer satisfied with simply treating the symptoms; instead, they are taking a more preventive approach by boosting their immune system to reduce the risk of developing flu & cold. Consumers now recognize the crucial role of a strong immune system in combating illnesses like colds and flu.

They are actively seeking ways to enhance their immune function and are turning to supplements that claim to provide immune support. These supplements often contain various vitamins, minerals, antioxidants, and herbal ingredients believed to boost immune function and promote overall wellness. Natural molecule-based supplements are often perceived as safer than pharmaceutical drugs, as they are derived from natural sources and are generally considered to have a lower risk of adverse effects. This perception of safety resonates with consumers who prefer a gentler and more natural approach to managing cold & flu symptoms. Furthermore, natural molecule-based supplements are increasingly available in various distribution channels, including pharmacies, hypermarkets & supermarkets, health food stores, online platforms, and specialty retailers.

Their visibility and accessibility are expected to drive their demand and consumption during the forecast period. Collaborations aimed at the distribution of nutritional and mineral supplements are likely to support market growth. For instance, in October 2022, Animine, a France-based company known for its production and distribution of precision minerals, partnered with Grupo ISA for the exclusive distribution of its products and solutions in Mexico. This collaboration is expected to strengthen Grupo ISA's portfolio of nutritional solutions and enable the company to offer a wider range of innovative products to the North American market.

Cold And Flu Supplements Market Report Highlights

  • The vitamins & minerals segment accounted for the largest share of 40.1% in 2022. These essential nutrients play a vital role in supporting immune function and overall well-being. Thus, they are commonly incorporated into cold and flu supplements to enhance immunity and aid in recovery
  • The pharmacies & drug stores segment accounted for the largest share of 48.5% in 2022. The primary reason behind the increased sales through this distribution channel is the presence of knowledgeable pharmacists who can offer expert guidance and advice to consumers seeking cold & flu supplements. This expertise instills consumer trust and contributes to higher sales figures
  • North America accounted for the largest share of over 36.4% of the global market in 2022. This can be attributed to the rising health consciousness among consumers in the region leading to a heightened interest in maintaining a healthy diet and lifestyle
  • The region's focus on wellness and preventive healthcare also drives the demand for cold & flu supplements

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Products & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Product Outlook
2.3. Distribution Channel Outlook
2.4. Regional Outlook
Chapter 3. Cold and Flu Supplements Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Industry Value Chain Analysis
3.2.1. Profit Margin Analysis
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Opportunities
3.3.4. Market Challenges
3.4. Industry Analysis - Porter’s Five Forces Analysis
3.5. Market Entry Strategies
Chapter 4. Consumer Behavior Analysis
4.1. Demographics Analysis
4.2. Consumer Trends and Preferences
4.3. Factors Affecting Buying Decision
4.4. Consumer Product Adoption
4.5. Key Observations & Findings
Chapter 5. Cold and Flu Supplements Market: Product Estimates & Trend Analysis
5.1. Product Movement Analysis & Market Share, 2022 & 2030
5.2. Vitamins & Minerals
5.2.1. Vitamins & minerals cold & flu supplements market estimates and forecast, 2017 - 2030 (USD Million)
5.3. Natural Molecules
5.3.1. Natural Molecules cold & flu supplements market estimates and forecast, 2017 - 2030 (USD Million)
5.4. Herbal Extract
5.4.1. Herbal extract cold & flu supplements market estimates and forecast, 2017 - 2030 (USD Million)
Chapter 6. Cold and Flu Supplements Market: Distribution Channel Range Estimates & Trend Analysis
6.1. Distribution Channel Movement Analysis & Market Share, 2022 & 2030
6.2. Pharmacies & Drug Stores
6.2.1. Cold & flu supplements market estimates and forecast through pharmacies & drug stores, 2017 - 2030 (USD Million)
6.3. Hypermarkets & Supermarkets
6.3.1. Cold & flu supplements market estimates and forecast through hypermarkets & supermarkets, 2017 - 2030 (USD Million)
6.4. Online
6.4.1. Cold & flu supplements market estimates and forecast through online, 2017 - 2030 (USD Million)
6.5. Others
6.5.1. Cold & flu supplements market estimates and forecast through other channels, 2017 - 2030 (USD Million)
Chapter 7. Cold and Flu Supplements Market: Regional Estimates & Trend Analysis
7.1. Regional Movement Analysis & Market Share, 2022 & 2030
7.2. North America
7.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.2.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.2.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.2.4. U.S.
7.2.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.2.4.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.2.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.2.5. Canada
7.2.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.2.5.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.2.5.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.2.6. Mexico
7.2.6.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.2.6.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.2.6.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.3. Europe
7.3.1.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.3.1.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.3.1.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.3.2.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.3.2.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.3.3.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.3.3.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.3.4.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.3.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.3.5.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.3.5.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.3.6.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.3.6.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.4.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.4.4. China
7.4.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.4.4.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.4.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.4.5. Japan
7.4.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.4.5.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.4.5.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.4.6. India
7.4.6.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.4.6.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.4.6.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.4.7. Australia & New Zealand
7.4.7.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.4.7.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.4.7.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.5. Central & South America
7.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.5.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.5.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.5.4. Brazil
7.5.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.5.4.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.5.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.6. Middle East & Africa
7.6.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.6.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.6.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
7.6.4. South Africa
7.6.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
7.6.4.2. Market estimates and forecast, by product, 2017 - 2030 (USD Million)
7.6.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
Chapter 8. Competitive Analysis
8.1. Recent developments & impact analysis, by key market participants
8.2. Company Categorization
8.3. Participant’s Overview
8.4. Financial Performance
8.5. Product Benchmarking
8.6. Company Market Share Analysis, 2022 (%)
8.7. Company Heat Map Analysis
8.8. Strategy Mapping
8.9. List of key companies analyzed in this section include:
8.9.1. Wakunaga of America, Co. Ltd
8.9.2. Neurobiologix, Inc.
8.9.3. KLAIRE LABS
8.9.4. Nordic Naturals
8.9.5. Himalaya Global Holdings Ltd.
8.9.6. Nature's Way Products, LLC
8.9.7. NU SKIN
8.9.8. Flora Inc.
8.9.9. Pfizer Inc.
8.9.10. Amway
8.9.11. NOW Foods
8.9.12. Nature's Sunshine Products, Inc.
8.9.13. The Vitamin Shoppe.
List of Tables
Table 1 Cold and flu supplements market estimates & forecast, by product (USD Million)
Table 2 Cold and flu supplements market estimates & forecast, by distribution channel (USD Million)
Table 3 U.S. macro - economic outlay
Table 4 Canada macro - economic outlay
Table 5 Mexico macro - economic outlay
Table 6 Germany macro - economic outlay
Table 7 UK macro - economic outlay
Table 8 France macro - economic outlay
Table 9 Italy macro - economic outlay
Table 10 Spain macro - economic outlay
Table 11 China macro - economic outlay
Table 12 Japan macro - economic outlay
Table 13 India macro - economic outlay
Table 14 Australia macro - economic outlay
Table 15 New Zealand macro - economic outlay
Table 16 Brazil macro - economic outlay
Table 17 South Africa macro - economic outlay
Table 18 Recent developments & impact analysis, by key market participants
Table 19 Company market share, 2022 (Value % Share)
Table 20 Company heat map analysis
Table 21 Companies undergoing product launches
Table 22 Companies undergoing partnerships
Table 23 Companies undergoing other strategies
List of Figures
Fig. 1 Cold and flu supplements market segmentation
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Primary research approaches
Fig. 5 Primary research process
Fig. 6 Cold and flu supplements market snapshot
Fig. 7 Cold and flu supplements market segment snapshot
Fig. 8 Competitive landscape snapshot
Fig. 9 Cold and flu supplements market size, 2017 to 2030 (USD Million)
Fig. 10 Cold and flu supplements market: Value chain analysis
Fig. 11 Cold and flu supplements market: Profit - margin analysis
Fig. 12 Cold and flu supplements market: Market dynamics
Fig. 13 Cold and flu supplements market: Porter’s five force analysis
Fig. 14 Percentage of consumers buying more immune - boosting products in the U.S., by age group, in 2021
Fig. 15 Percentage of consumers buying more immune - boosting products in the U.S., by income group, in 2021
Fig. 16 Factors affecting buying decision
Fig. 17 Cold and Flu Supplements Market, by Product: Key Takeaways
Fig. 18 Cold and Flu Supplements Market, by Product: Market share, 2022 & 2030
Fig. 19 Cold and flu supplements market estimates & forecast, by natural molecules, 2017 - 2030 (USD Million)
Fig. 20 Cold and flu supplements market estimates & forecast, by herbal extracts, 2017 - 2030 (USD Million)
Fig. 21 Cold and flu supplements market estimates & forecast, by vitamins & minerals, 2017 - 2030 (USD Million)
Fig. 22 Cold and Flu Supplements Market, by Distribution Channel: Key Takeaways
Fig. 23 Cold and Flu Supplements Market, by Distribution Channel: Market share, 2022 & 2030
Fig. 24 Cold and flu supplements market estimates & forecast through hypermarkets & supermarkets, 2017 - 2030 (USD Million)
Fig. 25 Cold and flu supplements market estimates & forecast through pharmacies & drugstores, 2017 - 2030 (USD Million)
Fig. 26 Cold and flu supplements market estimates & forecast through online channel, 2017 - 2030 (USD Million)
Fig. 27 Cold and flu supplements market estimates & forecast through other channels, 2017 - 2030 (USD Million)
Fig. 28 Cold and flu supplements market revenue, by region, 2022 & 2030 (USD Million)
Fig. 29 Regional marketplace: Key takeaways
Fig. 30 North America cold and flu supplements market estimates & forecasts, 2017 - 2030 (USD Million)
Fig. 31 U.S. cold and flu supplements market estimates & forecast, 2017 - 2030 (USD Million)
Fig. 32 Flu activity peak months in the U.S., from 1982 - 1983 through 2021 - 2022 flu seasons
Fig. 33 Canada cold and flu supplements market estimates & forecast, 2017 - 2030 (USD Million)
Fig. 34 Mexico cold and flu supplements market estimates & forecast, 2017 - 2030 (USD Million)
Fig. 35 Europe cold and flu supplements market estimates & forecasts, 2017 - 2030 (USD Million)
Fig. 36 Germany cold and flu supplements market estimates & forecast, 2017 - 2030 (USD Million)
Fig. 37 UK cold and flu supplements market estimates & forecast, 2017 - 2030 (USD Million)
Fig. 38 France cold and flu supplements market estimates & forecast, 2017 - 2030 (USD Million)
Fig. 39 Italy cold and flu supplements market estimates & forecast, 2017 - 2030 (USD Million)
Fig. 40 Spain cold and flu supplements market estimates & forecast, 2017 - 2030 (USD Million)
Fig. 41 Asia Pacific cold and flu supplements market estimates & forecasts, 2017 - 2030 (USD Million)
Fig. 42 China cold and flu supplements market estimates & forecast, 2017 - 2030 (USD Million)
Fig. 43 Japan cold and flu supplements market estimates & forecast, 2017 - 2030 (USD Million)
Fig. 44 India cold and flu supplements market estimates & forecast, 2017 - 2030 (USD Million)
Fig. 45 Australia & New Zealand cold and flu supplements market estimates & forecast, 2017 - 2030 (USD Million)
Fig. 46 Central and South America cold and flu supplements market estimates & forecasts, 2017 - 2030 (USD Million)
Fig. 47 Brazil cold and flu supplements market estimates & forecast, 2017 - 2030 (USD Million)
Fig. 48 Influenza deaths in Brazil, 2016 - 2022 (January & February)
Fig. 49 Middle East & Africa cold and flu supplements market estimates & forecasts, 2017 - 2030 (USD Million)
Fig. 50 South Africa cold and flu supplements market estimates & forecast, 2017 - 2030 (USD Million)
Fig. 51 Key company categorization
Fig. 52 Company market share analysis, 2022 (in %)
Fig. 53 Strategic Framework

Companies Mentioned

  • Wakunaga of America, Co. Ltd
  • Neurobiologix, Inc.
  • KLAIRE LABS
  • Nordic Naturals
  • Himalaya Global Holdings Ltd.
  • Nature's Way Products, LLC
  • NU SKIN
  • Flora Inc.
  • Pfizer Inc.
  • Amway
  • NOW Foods
  • Nature's Sunshine Products, Inc.
  • The Vitamin Shoppe.

Methodology

Loading
LOADING...

Table Information